Q Biomed (QBIO) News Today Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsBuy This Stock QBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q BioMed IncApril 8, 2025 | uk.investing.comOrchestra Biomed Reports Q3 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comOrchestra BioMed Reports Q3 2024 Results, Advances Key Clinical ProgramsNovember 14, 2024 | msn.comIBM's newest 156-qubit quantum chip can run 50 times faster than its predecessor — equipping it for scientific researchNovember 14, 2024 | msn.comA Powerful New Tool for Biomedical ResearchSeptember 12, 2024 | msn.comClearside Biomedical Q4 2023 Earnings PreviewMarch 11, 2024 | msn.comQ BioMed Stock (OTC:QBIO) Dividends: History, Yield and DatesFebruary 24, 2024 | benzinga.comBiogen Inc. (BIIB) Lags Q4 Earnings and Revenue EstimatesFebruary 13, 2024 | msn.comBioxyne’s Q2 FY24 revenue surpasses $2.5m on Aussie medicinal cannabis growthJanuary 28, 2024 | msn.comQ BioMed Inc QBIONovember 16, 2023 | morningstar.comMQBIO Q BioMed Inc.August 18, 2023 | seekingalpha.comQ BioMed receives US patent and notice of allowance in Europe for Uttroside B; seeks ways to boost shareholder valueApril 14, 2023 | proactiveinvestors.comQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for EuropeApril 14, 2023 | finance.yahoo.comQ BioMed Stock (OTC:QBIO), Quotes and News SummaryMarch 3, 2023 | benzinga.comQ BioMed gets notice of allowable US patent for liver cancer treatment Uttroside BFebruary 10, 2023 | proactiveinvestors.comQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent OfficeFebruary 10, 2023 | finance.yahoo.comShort Volatility Alert: Q Biomed IncJanuary 12, 2023 | benzinga.comQ BioMed Inc. (QBIO)January 1, 2023 | finance.yahoo.comQ BioMed boosted by multi-million dollar asset as it converts long-term royalty into equity stake in Mannin ResearchNovember 14, 2022 | proactiveinvestors.comQ BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.November 14, 2022 | finance.yahoo.comQ BIOMED PROVIDES SHAREHOLDER UPDATEOctober 11, 2022 | prnewswire.comQ Biomed announces patent for groundbreaking GDF15 biomarker for glaucoma detection and treatmentSeptember 27, 2022 | proactiveinvestors.comQ BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKERSeptember 27, 2022 | finance.yahoo.comTraders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc.August 25, 2022 | finance.yahoo.comQ BioMed Inc. Provides Update to ShareholdersJuly 29, 2022 | finance.yahoo.comQ BioMed welcomes study that highlights the safety and efficacy of Uttroside-B chemotherapeuticJuly 26, 2022 | proactiveinvestors.comQ BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancerJuly 26, 2022 | finance.yahoo.comQ BioMed Inc (QBIO)May 11, 2022 | investing.comQ BioMed says its strategy is paying off as it outlines its value proposition in multibillion-dollar marketsMay 6, 2022 | proactiveinvestors.comQ BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar MarketsMay 6, 2022 | finance.yahoo.comQ BioMed announces publication of research supporting efficacy and development of its Uttroside-B chemotherapeutic to treat liver cancerMarch 16, 2022 | proactiveinvestors.comQ BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancerMarch 16, 2022 | finance.yahoo.comQ BioMed expands Strontium89 to Chinese market with $500K orderMarch 7, 2022 | seekingalpha.comQ BioMed Announces Initial $500k Order of Strontium89 to Chinese MarketMarch 7, 2022 | finance.yahoo.comQ BioMed outlines strategic direction and goals for 2022February 14, 2022 | proactiveinvestors.comQ BioMed Outlines Strategic Direction for 2022February 14, 2022 | finance.yahoo.comQ BioMed says it is seeing a ‘significant uptrend’ in revenues as it continues to roll out Strontium89December 16, 2021 | proactiveinvestors.comNA Proactive news snapshot: Q BioMed Inc, FansUnite Entertainment Inc, BioSig Technologies Inc, Endexx Corporation, Doré Copper ...December 16, 2021 | proactiveinvestors.comQ BioMed Shows Significant Uptrend in Revenues in Year-End UpdateDecember 16, 2021 | finance.yahoo.comQ BioMed to forms partnership with EVERSANA to help commercialize Strontium89November 8, 2021 | proactiveinvestors.comQ BioMed Bolsters Commercialization of Strontium89 with EVERSANA PartnershipNovember 8, 2021 | finance.yahoo.comQ BioMed raises $2M with plans for uplisting on NASDAQ; updates on activity for coming monthsOctober 25, 2021 | proactiveinvestors.comQ BioMed Inc. Provides Shareholder UpdateOctober 25, 2021 | finance.yahoo.comQ BioMed sees uptick in 4Q sales of Strontium89 amid commercial rolloutSeptember 28, 2021 | proactiveinvestors.comQ BioMed Inc. Provides Update on Strontium89 Commercial Roll Out Revenue Up in 4th Quarter with Positive TrendSeptember 28, 2021 | finance.yahoo.comFinancialNewsMedia.com: Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and VariantsSeptember 22, 2021 | finanznachrichten.deQ BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022September 22, 2021 | finance.yahoo.comQ BioMed expects to receive South Korean patent for its liver cancer chemotherapy candidateAugust 25, 2021 | proactiveinvestors.comQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent in South Korea and Shows Promising Results in Initial Pre-Clinical TestingAugust 24, 2021 | finance.yahoo.comQ BioMed strikes distribution agreement for Strontium89 sales in CanadaAugust 10, 2021 | proactiveinvestors.com Get Q Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QBIO Media Mentions By Week QBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QBIO News Sentiment▼0.001.11▲Average Medical News Sentiment QBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QBIO Articles This Week▼00▲QBIO Articles Average Week Get the Latest News and Ratings for QBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Q Biomed and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FFNTF News AIMDW News AGNPF News ALST News AZNCF News AVXT News BCTXW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:QBIO) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q Biomed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Q Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
